Triplet Induction + 1 or 2-Drug Maintenance
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance
Near Add Your Location
Sorting 370 by
Hematology Oncology Consultants (Clarkston)
Clarkston, MI
- Accepting patients
St. Joseph Mercy Canton Health Center
Canton, MI
- Accepting patients
Sanford Cancer Center
Sioux Falls, SD
- Accepting patients
Central Care Cancer Center
Bolivar, MO
- Accepting patients
Essentia Health - Ashland Clinic
Ashland, WI
- Accepting patients
Marshfield Clinic - Wisconsin Rapids
Wisconsin Rapids, WI
- Accepting patients
Illinois CancerCare (Macomb)
Macomb, IL
- Accepting patients
Providence Regional Cancer System (Aberdeen)
Aberdeen, WA
- Accepting patients
- Accepting patients
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.